Details
|
Unigene Laboratories, inc. focuses on research, manufacturing and delivery of peptides for medical indications. Unigene’s products include parathyroid hormone analog for cure osteoporosis, oral insulin, nasal calcitonin, injectable calcitonin, oral calcitonin indicated to treat osteoporosis; oral desmopressid for the cure of primary nocturnal enuresis, as well as analogs and regulatory peptides prescribed for the treatment type 1 and type 2 diabetes. The company offers nasal and oral delivery technologies to bring medically useful amounts of different pertides into the bloodstream. The industry’s injectable calcitonin product is approved for sale in Switzerland and European Union for osteoporosis use. Unigene laboratories was established in 1980 and is headquartered in Fairfield, New Jersey and is publicly traded under stock symbol: UGNE.
|
